PATENT CLAIM ANALYSIS

Application Number: 16199818
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "086000"]

Abstract:
Methods for inhibiting a ROS1 kinase with compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R 2 , R 2a , R 3 , R 3a , and Z are as defined herein. The compounds and methods provided herein are useful in the treatment of cancer (e.g., ROS1-associated cancers as defined herein).

Claim (Index 15):
The method of  claim 1 , wherein the compound is entrectinib, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 98.0
- Lexical Diversity: 1.4898
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15632187', '15401839', '15401952', '14575663', '13698922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8791613807580804
- 35 USC 102 Novelty (BERT): 0.6492538712134234
- Combined Prediction Score: 0.8561706298036147
- Mean Citation Score: 671.958312
- Max Citation Score: 686.9997599999998
- Similarity Product: 474.2066888008402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test